IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3756 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Patients and Methods
   DIF was performe...
   Results
   Discussion
   References

 Article Access Statistics
    Viewed5495    
    Printed93    
    Emailed3    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
CLINICAL STUDIES
Year : 1998  |  Volume : 64  |  Issue : 3  |  Page : 150-152

Direct Immunofluorescence in Lesional and Uninvolved Skin in Dle




Correspondence Address:
A Sandra


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20921748

Rights and PermissionsRights and Permissions

  Abstract 

Direct immunofluroscence was evaluated in 16 patients with DLE including 1 case of lupus profundus and 4 with disseminated DLE. A BMZ band with multiple immunoreactants was demonstrated in lesional skin in 14 patients (87.5%), while 2 had only single immunoreactants. C3 and lgM were the commonest reactants followed by lgG, lgA and fibrinogen. A perifollicular prominence was seen in several patients. Four patients showed a band in uninvolved skin. This may indicate a potential to develop SLE. ANA was also positive in 5 patients but ds DNS was negative.



How to cite this article:
Sandra A, Srinivas C R, Balachandran C, Shenoi S D. Direct Immunofluorescence in Lesional and Uninvolved Skin in Dle. Indian J Dermatol Venereol Leprol 1998;64:150-2

How to cite this URL:
Sandra A, Srinivas C R, Balachandran C, Shenoi S D. Direct Immunofluorescence in Lesional and Uninvolved Skin in Dle. Indian J Dermatol Venereol Leprol [serial online] 1998 [cited 2020 May 31];64:150-2. Available from: http://www.ijdvl.com/text.asp?1998/64/3/150/4677



  Introduction Top


In the lupus erythematosus spectrum of disease discoid lupus erythematosus (DLE) represents a relatively benign disorder of the skin, consisting of a localised form with lesions confined to above the neck, and a disseminated form in which lesions also occur on trunk and limbs.[1] The immunoreactants deposited at the dermo-epidermal junction (DEJ) can be demonstrated by direct immunofluorescence (DIF) as a characteristic lupus band, which is seen in lesional skin only in DLE and both in lesional and uninvolved skin in SLE.[2] A small percentage of DLE patients usually of the disseminated variety can progress to develop SLE.[1] This study was undertaken to define the DIF findings in lesional and uninvolved (exposed and covered) skin in patients with DLE.


  Patients and Methods Top


Sixteen patients with DLE including 1 with lupus profundus and 4 with disseminated lesions were studied. Lesional skin from all patients and uninvolved exposed skin (extensor forearm) and covered skin (buttocks) from 14 patients were biopsied for DIF studies.


  DIF was performed as follows;- Top


The specimens were washed in phosphate buffered saline (PBS), snap frozen using liquid nitrogen and stored in the deep freezer at -70c. Frozen sections (6-8) were obtained and incubated with FITC (fluorescein isothiocyanate) conjugated rabbit anti-human antibodies (DAKO) to IgG, IgM, IgA,C3 and fibrinogen respectively for about an hour. After washing in PBS (three 10 munute changes) and air drying, the sections were mounted using buffered glycerol and observed with a fluorescence microscope (Leitz Laborluk D). The class of immunoreactants, sites, patern and intensity of staining were noted. An ANA assay by indirect enzyme immunoassay using wells coated with Hep-2 nuclear extract antigen (DIASTAT Kit), LE cell test (by rotatory bead method) and anti-double stranded DNA (dsDNa) were also done in 14 patients. Histopathology (HPE) was performed in 12 cases.


  Results Top


Sixteen patients (13 females, 3 males) ranging in age from 22 to 48 years with a mean age of 36.25 years with lesions clinically suggestive of DLE were studied. Scalp was the comonest site of involvement (11 patients) and in 5 of them this was the only site involved. Other sites involved were ears, nose, cheek and lips. Four patients had disseminated DLE with lesions below the neck. Duration of disease varied from 8 months to 10 years (mean duration 3-43 years). Histopathology was consistent with DLE in all. DIF results are shown in [Table:1]. In 5 patients the basement membrane zone (BMZ) band tended to be discontinuous with some immunoreactants but had a perifollicular prominence [Figure:1] Intensity of staining also varied between immunoreactants and IgM usually showed the strongest deposits. Ten patients had a predominently granular pattern of deposits while it was more homogeneous in 5 with granules scattered within the band. Four patients showed a BMZ band in the exposed skin and 3 of them also had discontinuous bands in covered skin. 5 patients had a positive ANA test, but dsDNA and LE cell test were negative in all. The correlation of patients with uninvolved skin and ANA positivity are shown in [Table:2].

The patient with lupus profundus had lesions over both cheeks, and lesional skin showed a thick strongly positive, homogenous to granular band of IgM,IgA,C3 and fibrin. Her exposed uninvolved skin showed a moderately positive IgM band with fibrillar extension into the upper dermis. H & E was consistent with lupus profundus. ANA was positive but dsDNA and LE cell tests were negative.


  Discussion Top


High diagnostic sensitivity of upto 90% has baeen reported with the DIF test in DLE.[2-4] Others have reported it to be a less sensitive test. [5,6] In this study a BMZ band was seen at least with one immunoreactant in all patients and, with multiple immunoreactants in 14 patients (87.5%) in lesional skin [Table:3]. The high percentage of positivity in this study could be because all the patients had lesions for a longer duration and most of the lesional biopsies were from scalp or retroauricular area, as early lesion (<2 months) and those on the trunk tend to be negative when compared to scalp lesions which are almost always positive.[3] In the two Indian studies, Joshi et al[7] reported a positive band in 4 of 6 patients studied while George et at[6] found lesional lupus band in 15 of 26 patients (58%) only. Although uninvolved skin is expected to be begative in DLE, four of our patients had uninvolved skin BMZ band and I had epidermal nuclear staining, all 5 patients had a ositive ANA assy in addition. George et al[6] also reported band in exposed skin in one of 3 patients studied. This could indicate a potential to progress to SLE and hence would call for a closer monitoring of these patients.[8]

 
  References Top

1.Rowell NR, Goodfield MJD. The connective tissue diseases, In Textbook of Dermatology, Edited by Champion RH, Burton JL, Ebling FJG, 5th edn. vol3, Blackwell Scientific Publication Oxford, 1992;2163-2225.  Back to cited text no. 1    
2.Ongley RC. Immunofluorescent microscopy in dermatology: Diganostic applications. Int J Dermatol 1982;21:233-240.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Weigand DA. Cutaneous immunofluorescence. Collagen vascular disease, Med Clin N Am 1989;73:1263-1274.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Neumann HA, Berretty PJ, Faber WR.Immunoglobulin deposits on vascular walls in cutaneous lupus erythematosus, Immunofluorescence study. Ann Dermatol Venereol 1982;109:649-653.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Weignad DA. The lupus band test: a reevaluation. J Am Acad Dermatol 1984;11:230-234.  Back to cited text no. 5    
6.George R, Mathai R, Kurian S. Cutaneous lupus erythematosus in India. Immunofluorescence profile. Int J Dermatol 1992;31:265-290.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Joshi R, Mittal B, Gupte P, et al. Direct immunofluorescence studies on skin biopsies in lupus erythematosus: J Postgrad Med 1988;34:165-168.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Nieboer C. The reliability of immunofluorescence and his topathology in the diagnosis of discoid lupus erythematosus and lichen planus. Br J Dermatol 1987;116:189-198.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]




 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow